Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ahmed Musa

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
BMJ Open|December 15, 2023
Haematological dynamics following treatment of visceral leishmaniasis: a protocol for systematic review and individual participant data (IPD) meta-analysisAbdalla Munir, Prabin Dahal, Rishikesh Kumar, et al.
Biofactors (Oxford, England)|June 14, 2017
Ezrin as a possible diagnostic and/or prognostic biomarker in mice lymphatic metastatic hepatocellular carcinoma in vivoAhmed Musa Hago Bakheet, Salma Abdi Mahmoud, Yuhong Huang, et al.
Plos Neglected Tropical Diseases|April 16, 2024
Post-kala-azar dermal leishmaniasis (PKDL) drug efficacy study landscape: A systematic scoping review of clinical trials and observational studies to assess the feasibility of establishing an individual participant-level data (IPD) platformSauman Singh-Phulgenda, Rishikesh Kumar, Prabin Dahal, et al.
Plos Neglected Tropical Diseases|September 15, 2016
Efficacy and Safety of AmBisome in Combination with Sodium Stibogluconate or Miltefosine and Miltefosine Monotherapy for African Visceral Leishmaniasis: Phase II Randomized TrialMonique Wasunna, Simon Njenga, Manica Balasegaram, et al.
Conflict and Health|June 23, 2025
Exploring diabetic patients experiences during war in Sudan: insights from a multi-city studyMohamed Hisham Alamin, Manasik Mamoun, Leina Elfatih Salah Mohamed Ali Elomeiri, et al.
BMC Medicine|January 15, 2026
Determinants of long-term SARS-CoV-2 immune responses in asymptomatic-to-moderate COVID-19 patients in sub-Saharan AfricaVíctor L de Rioja, Odin Goovaerts, Marta Vidal, et al.
Plos Neglected Tropical Diseases|November 5, 2010
Geographical variation in the response of visceral leishmaniasis to paromomycin in East Africa: a multicentre, open-label, randomized trialAsrat Hailu, Ahmed Musa, Monique Wasunna, et al.
Plos Neglected Tropical Diseases|June 23, 2012
Sodium stibogluconate (SSG) & paromomycin combination compared to SSG for visceral leishmaniasis in East Africa: a randomised controlled trialAhmed Musa, Eltahir Khalil, Asrat Hailu, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
BMJ Open|December 15, 2023
Haematological dynamics following treatment of visceral leishmaniasis: a protocol for systematic review and individual participant data (IPD) meta-analysisAbdalla Munir, Prabin Dahal, Rishikesh Kumar, et al.
Biofactors (Oxford, England)|June 14, 2017
Ezrin as a possible diagnostic and/or prognostic biomarker in mice lymphatic metastatic hepatocellular carcinoma in vivoAhmed Musa Hago Bakheet, Salma Abdi Mahmoud, Yuhong Huang, et al.
Plos Neglected Tropical Diseases|April 16, 2024
Post-kala-azar dermal leishmaniasis (PKDL) drug efficacy study landscape: A systematic scoping review of clinical trials and observational studies to assess the feasibility of establishing an individual participant-level data (IPD) platformSauman Singh-Phulgenda, Rishikesh Kumar, Prabin Dahal, et al.
Plos Neglected Tropical Diseases|September 15, 2016
Efficacy and Safety of AmBisome in Combination with Sodium Stibogluconate or Miltefosine and Miltefosine Monotherapy for African Visceral Leishmaniasis: Phase II Randomized TrialMonique Wasunna, Simon Njenga, Manica Balasegaram, et al.
Conflict and Health|June 23, 2025
Exploring diabetic patients experiences during war in Sudan: insights from a multi-city studyMohamed Hisham Alamin, Manasik Mamoun, Leina Elfatih Salah Mohamed Ali Elomeiri, et al.
BMC Medicine|January 15, 2026
Determinants of long-term SARS-CoV-2 immune responses in asymptomatic-to-moderate COVID-19 patients in sub-Saharan AfricaVíctor L de Rioja, Odin Goovaerts, Marta Vidal, et al.
Plos Neglected Tropical Diseases|November 5, 2010
Geographical variation in the response of visceral leishmaniasis to paromomycin in East Africa: a multicentre, open-label, randomized trialAsrat Hailu, Ahmed Musa, Monique Wasunna, et al.
Plos Neglected Tropical Diseases|June 23, 2012
Sodium stibogluconate (SSG) & paromomycin combination compared to SSG for visceral leishmaniasis in East Africa: a randomised controlled trialAhmed Musa, Eltahir Khalil, Asrat Hailu, et al.
Pageof 5